Genevieve Martin
banner
genevieveemart1.bsky.social
Genevieve Martin
@genevieveemart1.bsky.social
Australian doctor and scientist. PhD in HIV immunology. #IDSky
Reposted by Genevieve Martin
Why do some people get seriously ill while others don't? Our new study in @pnas.org investigated how a population of memory T cells influence #COVID severity

Read the paper: go.unimelb.edu.au/4zkp
Or our article here: go.unimelb.edu.au/2zkp

@katherinekedz.bsky.social @thedohertyinst.bsky.social
HLA-B*15:01-positive severe COVID-19 patients lack CD8+ T cell pools with highly expanded public clonotypes | PNAS
Understanding host factors driving asymptomatic versus severe disease outcomes is of key importance if we are to control emerging and re-emerging v...
go.unimelb.edu.au
September 5, 2025 at 8:14 AM
Reposted by Genevieve Martin
NEW STUDY | Menzies’ researchers have led the largest-ever study of people living with a unique strain of chronic hepatitis B (C4 hep B), uncovering significant impacts on liver health. Learn more about these findings and the work of the Hep B PAST Plus program: www.menzies.edu.au/page/News_an...
July 14, 2025 at 4:30 AM
Thrilled to share our new research led by Jane Davies @menziesresearch.bsky.social on First Nations people in the NT living with chronic hepatitis B. An important study that could inform better care:

doi.org/10.1186/s128...

#idsky #MedSky #HepSky #LiverSky
July 2, 2025 at 1:31 AM
Excited to have contributed to the updated version of the Tropical Health Orientation Manual which has just been published by @menziesresearch.bsky.social 🐊🧫😷 #idsky
Are you a health practitioner working in northern Australia? The Tropical Health Orientation Manual (THOM) 2025 provides best practice advice for diagnosis, identification & treatment of conditions specific to the tropical north. Download: tinyurl.com/ahw6jyk8
July 1, 2025 at 11:59 PM
Reposted by Genevieve Martin
particularly acute kidney injury, bone marrow suppression, and severe cutaneous reactions, affecting over 50% of patients exposed. Notably, 44% required cessation or dose reduction due to toxicity
www.sciencedirect.com/science/arti...

www.sciencedirect.com/science/arti...
@idsainfo.bsky.social
Low-Dose Trimethoprim/Sulfamethoxazole for Melioidosis Eradication Therapy: A Clinically Tolerable Alternative.
www.sciencedirect.com
June 21, 2025 at 4:45 AM
The wet season has arrived! ⛈️ Sharing our two new papers on clinical aspects of melioidosis 🧫 in the Top End of Australia 🐊🇦🇺 — work done with Prof Bart Currie and Prof Jane Davies at Menzies School of Health Research #IDSky
December 8, 2024 at 4:35 AM